Council on Foreign Relations’ “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part I
Yanzhong Huang, CFR senior fellow for global health, examines the history of artemisinin drug development in China during the Cold War era. “…It would take another two decades before [artemisinin-combination therapies (ACTs)] were officially adopted by the World Health Organization (WHO) as frontline drugs in the global fight against malaria. Paradoxically, even today artemisinin-based drugs made in China only accounts for one percent of the international market share. Why? This will be the subject of my next blog post” (2/27).